Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02753751 · ClinicalTrials.gov registry record · NA
Optimizing Electronic Alerts for Acute Kidney Injury
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 6,030
- Enrollment target
NCT02753751: Completed NA study, sponsored by Yale University.
NCT02753751 is a NA study that has completed, run by Yale University. The registered enrollment target is 6,030 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (330% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02753751, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 6,030 participants
- Enrollment target
Study Summary
This study will enroll hospitalized adults with acute kidney injury (AKI) and randomize them to usual care versus an electronic alert coupled to a "best practices" order set.
Primary Outcome
Progression of AKI is defined by an increase in KDIGO creatinine stage from that present at the time of randomization. Dialysis is defined by the receipt of hemodialysis, continuous renal replacement therapy or peritoneal dialysis. Isolated ultrafiltration treatments (for the purpose of volume removal) will not be included. Mortality will be determined from hospital administrative records.
Interventions
- OTHER AKI Alert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,030 participants |
| Start Date | 2018-03-26 |
| Est. Completion | 2020-01-06 |
| Phase | NA |
What the finished NCT02753751 record still lists
NCT02753751 is an interventional study that assigns participants to a tested intervention. Its 6,030 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (330% higher).
The record links to 0 conditions, and to 1 intervention - of which AKI Alert is the first listed.
NCT02753751 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02753751 about?
NCT02753751 is a clinical study titled "Optimizing Electronic Alerts for Acute Kidney Injury". This study will enroll hospitalized adults with acute kidney injury (AKI) and randomize them to usual care versus an electronic alert coupled to a "best practices" order set.
What is the current status of trial NCT02753751?
This trial is currently completed. It is a NA study. The enrollment target is 6,030 participants. The study started on 2018-03-26. Estimated completion is 2020-01-06.
What interventions are being tested in trial NCT02753751?
The interventions under investigation include: AKI Alert (OTHER).
Who is sponsoring clinical trial NCT02753751?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02753751's enrollment target sits among peer trials
6,030 22nd of 2000 higher than 1,979 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05884190 · 6,030 participants · NA
Trauma-informed Approach to Timely Detection and Management of Early Postpartum Hypertension
- NCT00005095 · 6,000 participants
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
- NCT00280202 · 6,000 participants
Detection of Genetic Markers of Lung Cancer
- NCT03127631 · 6,000 participants · NA
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI